The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,960.00
Bid: 1,969.00
Ask: 1,971.00
Change: 35.00 (1.82%)
Spread: 2.00 (0.102%)
Open: 1,937.00
High: 1,977.00
Low: 1,931.00
Prev. Close: 1,925.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Britain's FTSE hits record highs, extends historic winning streak

Fri, 13th Jan 2017 16:54

* FTSE 100 touches new record, sets 14th day of gains

* Pharmaceuticals rebound after Trump scare

* Housebuilders top the index

* ITV buoyed by broker optimism (Adds details and updates prices at close)

By Kit Rees and Helen Reid

LONDON, Jan 13 (Reuters) - Britain's blue-chip share indexreached record highs on Friday, extending its historic winningstreak to a 14th straight day of gains.

The index's longest winning run since its inception in 1984has also been notable for the relatively modest daily gains.After touching an all-time record high of 7,338.49 points, itended the session at a record closing level of 7,337.81 points,up 0.6 percent.

"There are people who want to say this is the moment it'sgoing to turn around, but each day they get proven wrong," IGmarket analyst Josh Mahony said.

He added that a likely further devaluation of the pound inthe next months would support the index higher. "But the gainsare not exuberant."

Brokers pushed broadcaster ITV towards the top ofthe FTSE. Goldman Sachs added the stock to its conviction list,saying it is a likely M&A target. The broadcaster was also oneof JPMorgan's top picks in the European media sector.

House-builders also helped the FTSE rally, with houseimprovement company Kingfisher marking its best daily gain sinceSeptember. Barratt Development led sectoral gains.Persimmon and Taylor Wimpey also gained 1.4percent and 0.9 percent respectively.

"If you want to sleep at night, you'd probably buy aPersimmon or Taylor Wimpey. If you want a bit more rock androll, you might buy a Redrow or a Bovis," Jefferiesanalyst Anthony Coding said.

Pharmaceuticals were buoying the index, rebounding afterbeing weighed down on Thursday by U.S. President-elect DonaldTrump's criticism of high drug prices, and after a meeting ofexecutives of companies including Britain's Shire todiscuss caps on price increases.

Shares in Shire were up 2.3 percent, and peers AstraZeneca and Hikma also gained, up 2 and 1.2 percent.

Rolls Royce dragged on the index, down more than 2percent, while precious metals miners Randgold Resources and Polymetal International Fresnillo lost around 1.4percent, tracking the price of gold, which was down from a7-week high.

Building materials supplier SIG surged to the top of themid-cap index, up 16.1 percent after it reported higherfull-year sales. Its shares marked their biggest one-day gainsince March 2009. Blue chip Travis Perkins was up 3percent, and peer Grafton also gained 8.4 percent. (Reporting by Kit Rees and Helen Reid; Editing by AngusMacSwan)

More News
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more
3 Jan 2023 09:24

LONDON BROKER RATINGS: Citigroup cuts Wizz Air; Redburn likes CRH

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning, Monday and late Friday:

Read more
3 Jan 2023 09:03

LONDON MARKET OPEN: Stocks jump in first session of 2023

(Alliance News) - Stock prices in London made a strong start to the new year on Tuesday, despite weak Chinese data and the UK suffering a fresh wave of rail strikes.

Read more
3 Jan 2023 07:58

LONDON BRIEFING: Stocks called higher; China factory sector shrinks

(Alliance News) - Stocks in London are expected to start a new year on the front foot on Tuesday, after a mixed session in Asia amid weak Chinese economic data.

Read more
3 Jan 2023 07:46

Hikma launches generic narcolepsy solution in US

(Sharecast News) - Hikma Pharmaceuticals has launched an authorised generic version of Jazz Pharmaceuticals' 'Xyrem 1', or sodium oxybate oral solution, it announced on Tuesday.

Read more
8 Dec 2022 09:48

LONDON BROKER RATINGS: JPMorgan cuts Travis Perkins; BofA likes IAG

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
6 Dec 2022 10:48

RBC Capital Markets starts Hikma at 'outperform'

(Sharecast News) - RBC Capital Markets initiated coverage of Hikma Pharmaceuticals on Tuesday at 'outperform' with a 1,750p price target.

Read more
6 Dec 2022 10:26

LONDON BROKER RATINGS: JPMorgan cuts Lloyds but raises Barclays

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
15 Nov 2022 12:10

Credit Suisse initiates coverage of Hikma at 'outperform'

(Sharecast News) - Credit Suisse has initiated coverage of Hikma Pharmaceuticals with an 'outperform' rating.

Read more
15 Nov 2022 09:58

LONDON BROKER RATINGS: Jefferies cuts Aston Martin to 'underperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
14 Nov 2022 09:25

LONDON BROKER RATINGS: Credit Suisse cuts Ferrexpo to 'neutral'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
8 Nov 2022 09:39

LONDON BROKER RATINGS: Peel cuts Persimmon; Liberum raises Hammerson

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
3 Nov 2022 11:17

Hikma Pharmaceuticals reiterates 2022 guidance as costs widen

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reiterated annual guidance for all three of its businesses, continuing to expect them to underperform against 2021 due to rising costs.

Read more
3 Nov 2022 11:08

With tighter purse strings, is parity less probable for the pound?

STOXX 600 down 1.1%

*

Read more
3 Nov 2022 09:28

Banks, insurance dodge carnage as real estate stocks sink

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at .

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.